Learn the 120-page report with TOC on “In-vitro Diagnostics Devices Market Evaluation Report by Product (Immunochemistry, Medical microbiology, Molecular diagnostics, and Others), Finish-user (Hospitals and diagnostic laboratories, Tutorial and analysis institutes, and House care), and Geography (North America, Europe, Asia, and ROW), and the Section Forecasts,2021-2025″. Achieve aggressive intelligence about market leaders. Observe key trade alternatives, traits, and threats. Info on advertising, model, technique and market growth, gross sales and provide features. https://www.technavio.com/report/report/in-vitro-diagnostics-instruments-market-industry-analysis
Key Market Dynamics
The in-vitro diagnostics devices market is attributed to rising geriatric inhabitants and demand for customized drugs. The prevalence of ailments, akin to lung illness, most cancers, and stroke, is excessive among the many growing old inhabitants. There’s a direct relationship between growing old and the susceptibility to infections, because the immune system deteriorates with age. The rise within the growing old inhabitants has additionally resulted in elevated expenditure on healthcare for well being check-ups, illness prognosis, and remedy. The aged inhabitants requires diagnostic testing usually because of their low immunity and metabolism. These components have elevated the demand for in-vitro diagnostics devices, as these devices help in illness prognosis.
Nevertheless, reimbursement insurance policies for diagnostic testing are usually not fixed throughout varied geographies, and they’re transferring in a downward pattern. Hospitals and diagnostic laboratories which are the first end-users are pressured to cut back their expenditure on in-vitro diagnostics devices to have both break even or worthwhile income. The US has comparable conditions for in-vitro diagnostics devices, and a discount of reimbursement by Medicare might restrict the demand for sure diagnostic testing throughout all segments. This has, in flip, affected the gross sales of latest devices for in-vitro diagnostics testing.
Find report sample PDF here to get a detailed market share analysis of market participants
Prime In-vitro Diagnostics Devices Corporations:
- Abbott Laboratories: The corporate affords in-vitro diagnostics devices particularly Sapphire, Ruby, Emerald 22AL, and others.
- Becton Dickinson and Co.: The corporate affords in-vitro diagnostics devices for mycobacteria testing, and identification and susceptibility techniques.
- Bio Rad Laboratories Inc.: The corporate affords in-vitro diagnostics devices to display screen of microbial presence, develop and establish organisms, and take a look at for antibiotic susceptibility.
- bioMerieux SA: The corporate affords in-vitro diagnostics devices for laboratory optimization.
- Danaher Corp. : The corporate affords in-vitro diagnostics devices particularly DxH 900, DxH 900 related workcell, DxH sildemaker stainer, DxH 690T, and Others.
- F. Hoffmann-La Roche Ltd.: The corporate affords in-vitro diagnostics devices for affected person self testing, care testing, and subsequent technology sequencing
- HORIBA Ltd.: The corporate affords in-vitro diagnostics devices akin to blood analysers, middleware/work ststion, monitoring system and others.
- Siemens AG: The corporate affords in-vitro diagnostics devices built-in with synthetic intelligence and deep studying expertise to cut back the failure charge of automated in vitro diagnostics.
- Sysmex Corp.: The corporate affords in-vitro diagnostics devices to detect medical indications in physiology, pathology, and and human homeostasis.
- Thermo Fisher Scientific Inc.: The corporate affords in-vitro diagnostics devices particularly Phadia, Endura MD, and Indiko.
Speak to our Analyst for customized report on each vendor
In-vitro Diagnostics Devices Market Product Outlook (Income, USD bn, 2020-2025)
- Immunochemistry – dimension and forecast 2020-2025
- Medical microbiology – dimension and forecast 2020-2025
- Molecular diagnostics – dimension and forecast 2020-2025
- Others – dimension and forecast 2020-2025
The immunochemistry product section held the biggest market share in 2020. The section will proceed to account for the biggest share all through the forecast interval. This section is the extremely automated section of scientific laboratories and represents the best take a look at quantity in contrast with the opposite varieties of testing.
In-vitro Diagnostics Devices Market Geography Outlook (Income, USD bn, 2020-2025)
- North America – dimension and forecast 2020-2025
- Europe – dimension and forecast 2020-2025
- Asia – dimension and forecast 2020-2025
- ROW – dimension and forecast 2020-2025
35% of the market’s development will originate from North America in the course of the forecast interval. US and Canada are the important thing markets for in-vitro diagnostics devices in North America. The rising growing old inhabitants and the excessive prevalence of continual and infectious ailments will gas the in-vitro diagnostics devices market development in North America over the forecast interval.
In-vitro Diagnostics Devices Market Finish-user Outlook (Income, USD bn, 2020-2025)
- Hospitals and diagnostic laboratories – dimension and forecast 2020-2025
- Tutorial and analysis institutes – dimension and forecast 2020-2025
- House care – dimension and forecast 2020-2025
Grab an exclusive free sample report on the contribution of each segment
Associated Stories:
In-Vitro Toxicity Testing Market by End-user and Geography – Forecast and Analysis 2022-2026
In-vitro Diagnostics Market by Technology and Geography – Forecast and Analysis 2021-2025
|
In-vitro Diagnostics Devices Market Scope |
|
|
Report Protection |
Particulars |
|
Web page quantity |
120 |
|
Base 12 months |
2020 |
|
Forecast interval |
2021-2025 |
|
Development momentum & CAGR |
Speed up at a CAGR of seven.95% |
|
Market development 2021-2025 |
$ 23.00 billion |
|
Market construction |
Fragmented |
|
YoY development (%) |
6.23 |
|
Regional evaluation |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 35% |
|
Key client international locations |
US, China, Germany, Canada, and UK |
|
Aggressive panorama |
Main corporations, Aggressive methods, Client engagement scope |
|
Key corporations profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., HORIBA Ltd., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Mother or father market evaluation, Market development inducers and obstacles, Quick-growing and slow-growing section evaluation, COVID 19 impression and restoration evaluation and future client dynamics, Market situation evaluation for the forecast interval |
|
Customization purview |
If our report has not included the info that you’re in search of, you’ll be able to attain out to our analysts and get segments custom-made. |
Desk of Content material
1. Government Abstract
2. In-vitro Diagnostics Devices Market Panorama
2.1 Market ecosystem
Exhibit 01: Mother or father market
2.2: Market Traits
2.2 Worth chain evaluation
Exhibit 03: Worth chain evaluation: Healthcare gear market
2.2.1 Analysis and growth
2.2.2 Inputs
2.2.3 Operations
2.2.4 Distribution
2.2.5 Advertising and marketing and gross sales
2.2.6 Put up-sales and providers
2.2.7 Business improvements
3. In-vitro Diagnostics Devices Market Sizing
3.1 Market definition
Exhibit 04: Choices of distributors included out there definition
3.2 Market section evaluation
Exhibit 05: Market segments
3.3 Market dimension 2020
3.4 Market outlook: Forecast for 2020 – 2025
3.4.1 Estimating development charges for rising and high-growth markets
3.4.2 Estimating development charges for mature markets
Exhibit 06: World – Market dimension and forecast 2020 – 2025 ($ million)
Exhibit 07: World market: 12 months-over-year development 2020 – 2025 (%)
4. 5 Forces Evaluation
4.1 5 Forces Abstract
Exhibit 08: 5 forces evaluation 2020 & 2025
4.2 Bargaining energy of consumers
4.3 Bargaining energy of suppliers
4.4 Menace of latest entrants
4.5 Menace of substitutes
4.6 Menace of rivalry
4.7 Market situation
Exhibit 14: Market situation – 5 forces 2020
5. In-vitro Diagnostics Devices Market Segmentation by Product
5.1 Market segments
The segments coated on this chapter are:
Immunochemistry
Medical microbiology
Molecular diagnostics
Others
Exhibit 15: Product – Market share 2020-2025 (%)
5.2 Comparability by Product
Exhibit 16: Comparability by Product
5.3 Immunochemistry – Market dimension and forecast 2020-2025
Exhibit 17: Immunochemistry – Market dimension and forecast 2020-2025 ($ million)
Exhibit 18: Immunochemistry – 12 months-over-year development 2020-2025 (%)
5.4 Medical microbiology – Market dimension and forecast 2020-2025
Exhibit 19: Medical microbiology – Market dimension and forecast 2020-2025 ($ million)
Exhibit 20: Medical microbiology – 12 months-over-year development 2020-2025 (%)
5.5 Molecular diagnostics – Market dimension and forecast 2020-2025
Exhibit 21: Molecular Diagnostics – Market dimension and forecast 2020-2025 ($ million)
Exhibit 22: Molecular diagnostics – 12 months-over-year development 2020-2025 (%)
5.6 Others – Market dimension and forecast 2020-2025
Exhibit 23: Others – Market dimension and forecast 2020-2025 ($ million)
Exhibit 24: Others – 12 months-over-year development 2020-2025 (%)
5.7 Market alternative by Product
Exhibit 25: Market alternative by Product
6. In-vitro Diagnostics Devices Market Segmentation by Finish-user
6.1 Market segments
Exhibit 26: Finish-user – Market share 2020-2025 (%)
6.2 Comparability by Finish-user
Exhibit 27: Comparability by Finish-user
6.3 Hospitals and diagnostic laboratories – Market dimension and forecast 2020-2025
Exhibit 28: Hospitals and diagnostic laboratories – Market dimension and forecast 2020-2025 ($ million)
Exhibit 29: Hospitals and diagnostic laboratories – 12 months-over-year development 2020-2025 (%)
6.4 Tutorial and analysis institutes – Market dimension and forecast 2020-2025
Exhibit 30: Tutorial and analysis institutes – Market dimension and forecast 2020-2025 ($ million)
Exhibit 31: Tutorial and analysis institutes – 12 months-over-year development 2020-2025 (%)
6.5 House care – Market dimension and forecast 2020-2025
Exhibit 32: House care – Market dimension and forecast 2020-2025 ($ million)
Exhibit 33: House care – 12 months-over-year development 2020-2025 (%)
6.6 Market alternative by Finish-user
Exhibit 34: Market alternative by Finish-user
7. Buyer panorama
Exhibit 35: Buyer panorama
8. Geographic Panorama
8.1 Geographic segmentation
Exhibit 36: Market share by geography 2020-2025 (%)
8.2 Geographic comparability
Exhibit 37: Geographic comparability
8.3 North America – Market dimension and forecast 2020-2025
Exhibit 38: North America – Market dimension and forecast 2020-2025 ($ million
Exhibit 39: North America – 12 months-over-year development 2020-2025 (%)
8.4 Europe – Market dimension and forecast 2020-2025
Exhibit 40: Europe – Market dimension and forecast 2020-2025 ($ million)
Exhibit 41: Europe – 12 months-over-year development 2020-2025 (%)
8.5 Asia – Market dimension and forecast 2020-2025
Exhibit 42: Asia – Market dimension and forecast 2020-2025 ($ million)
Exhibit 43: Asia – 12 months-over-year development 2020-2025 (%)
8.6 ROW – Market dimension and forecast 2020-2025
Exhibit 44: ROW – Market dimension and forecast 2020-2025 ($ million)
Exhibit 45: ROW – 12 months-over-year development 2020-2025 (%)
8.7 Key main international locations
Exhibit 46: Key main international locations
8.8 Market alternative by geography
Exhibit 47: Market alternative by geography
9. Drivers, Challenges, and Traits
9.1 Market drivers
9.1.1 Rising geriatric inhabitants
9.1.2 Demand for customized drugs
9.1.3 Product launches
9.2 Market challenges
9.2.1 Strained laboratory budgets and decreasing reimbursements affecting instrument gross sales
9.2.2 Restricted sustainability of smaller distributors
9.2.3 Discount in income of producers because of US medical machine tax insurance policies
9.2.4 Limitations of closed techniques in in-vitro diagnostics testing
Exhibit 48: Impression of drivers and challenges
9.3 Market traits
9.3.1 Potential alternatives for POL
9.3.2 Leasing of in-vitro diagnostics devices
9.3.3 Rising significance for promotional actions
9.3.4 Technological advances in in-vitro diagnostics
10. Vendor Panorama
10.1 Aggressive situation
10.2 Vendor panorama
Exhibit 40: Vendor Panorama
10.3 Panorama disruption
Exhibit 41: Panorama disruption
10.4 Business dangers
Exhibit 42: Business dangers
11. Vendor Evaluation
11.1 Distributors coated
Exhibit 43: Distributors coated
11.2 Market positioning of distributors
Exhibit 53: Market positioning of distributors
11.3 Abbott Laboratories
Exhibit 54: Abbott Laboratories – Overview
Exhibit 55: Abbott Laboratories – Enterprise segments
Exhibit 56: Abbott Laboratories – Key choices
Exhibit 57: Abbott Laboratories – Section focus
11.4 Becton Dickinson and Co.
Exhibit 58: Becton Dickinson and Co. – Overview
Exhibit 59: Becton Dickinson and Co. – Enterprise segments
Exhibit 60: Becton Dickinson and Co. – Key Information
Exhibit 61: Becton Dickinson and Co. – Key choices
Exhibit 62: Becton Dickinson and Co. – Section focus
11.5 Bio Rad Laboratories Inc.
Exhibit 63: Bio Rad Laboratories Inc. – Overview
Exhibit 64: Bio Rad Laboratories Inc. – Enterprise segments
Exhibit 65: Bio Rad Laboratories Inc. – Key Information
Exhibit 66: Bio Rad Laboratories Inc. – Key choices
Exhibit 67: Bio Rad Laboratories Inc. – Section focus
11.6 bioMerieux SA
Exhibit 68: bioMerieux SA – Overview
Exhibit 69: bioMerieux SA – Enterprise segments
Exhibit 70: bioMerieux SA – Key choices
Exhibit 71: bioMerieux SA – Section focus
11.7 Danaher Corp.
Exhibit 72: Danaher Corp. – Overview
Exhibit 73: Danaher Corp. – Enterprise segments
Exhibit 74: Danaher Corp. – Key Information
Exhibit 75: Danaher Corp. – Key choices
Exhibit 76: Danaher Corp. – Section focus
11.8 F. Hoffmann-La Roche Ltd.
Exhibit 77: F. Hoffmann-La Roche Ltd. – Overview
Exhibit 78: F. Hoffmann-La Roche Ltd. – Enterprise segments
Exhibit 79: F. Hoffmann-La Roche Ltd. – Key Information
Exhibit 80: F. Hoffmann-La Roche Ltd. – Key choices
Exhibit 81: F. Hoffmann-La Roche Ltd. – Section focus
11.9 HORIBA Ltd.
Exhibit 82: HORIBA Ltd. – Overview
Exhibit 83: HORIBA Ltd. – Enterprise segments
Exhibit 84: HORIBA Ltd. – Key choices
Exhibit 85: HORIBA Ltd. – Section focus
11.10 Siemens AG
Exhibit 86: Siemens AG – Overview
Exhibit 87: Siemens AG – Enterprise segments
Exhibit 88: Siemens AG – Key Information
Exhibit 89: Siemens AG – Key choices
Exhibit 90: Siemens AG – Section focus
11.11 Sysmex Corp.
Exhibit 91: Sysmex Corp. – Overview
Exhibit 92: Sysmex Corp. – Enterprise segments
Exhibit 93: Sysmex Corp. – Key choices
Exhibit 94: Sysmex Corp. – Section focus
11.12 Thermo Fisher Scientific Inc.
Exhibit 95: Thermo Fisher Scientific Inc. – Overview
Exhibit 96: Thermo Fisher Scientific Inc. – Enterprise segments
Exhibit 97: Thermo Fisher Scientific Inc. – Key Information
Exhibit 98: Thermo Fisher Scientific Inc. – Key choices
Exhibit 99: Thermo Fisher Scientific Inc. – Section focus
12. Appendix
12.1 Scope of the report
12.1.1 Market definition
12.1.2 Targets
12.1.3 Notes and caveats
12.2 Forex conversion charges for US$
Exhibit 82: Forex conversion charges for US$
12.3 Analysis Methodology
Exhibit 83: Analysis Methodology
Exhibit 84: Validation methods employed for market sizing
Exhibit 85: Info sources
12.4 Record of abbreviations
About Technavio
Technavio is a number one international expertise analysis and advisory firm. Their analysis and evaluation focuses on rising market traits and offers actionable insights to assist companies establish market alternatives and develop efficient methods to optimize their market positions.
With over 500 specialised analysts, Technavio’s report library consists of greater than 17,000 studies and counting, overlaying 800 applied sciences, spanning throughout 50 international locations. Their consumer base consists of enterprises of all sizes, together with greater than 100 Fortune 500 corporations. This rising consumer base depends on Technavio’s complete protection, in depth analysis, and actionable market insights to establish alternatives in current and potential markets and assess their aggressive positions inside altering market eventualities.
Contacts
Technavio Analysis
Jesse Maida
Media & Advertising and marketing Government
US: +1 844 364 1100
UK: +44 203 893 3200
E-mail: [email protected]
Web site: www.technavio.com/
SOURCE Technavio
